New α1-antitrypsin correctors disclosed in Sub21 patent

May 29, 2025

Sub21 Inc. has divulged α1-antitrypsin (SERPINA1) (Z-mutant) correctors reported to be useful for the treatment of α1-antitrypsin deficiency.

BioWorld Science Endocrine/metabolic Patents

23andme founder-led group outbids Regeneron for company

BioWorld

The 23andme Holding Co.’s saga came full circle with founder Anne Wojcicki regaining control of the bankrupt genetic testing company in a bidding battle against...

Today's news in brief

BioWorld

BioWorld briefs for June 17, 2025.

Elevidys’ second liver death hits Sarepta, sends DMD ripples

BioWorld

How the U.S. FDA might respond became a serious question for Wall Street as Sarepta Therapeutics Inc. made known a second death due to acute liver failure with...

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for June 17, 2025.

3D representation of tumor microenvironment

EACR 2025: Immune rewiring in cancer orchestrates tumor microenvironment

BioWorld Science

Among the presentations included in the Top Abstracts category at the recently inaugurated Annual Congress of the European Association for Cancer Research (EACR)...